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Feasibility of subendocardial and subepicardial
myocardial perfusion measurements in healthy
normals with 15O-labeled water and positron
emission tomography
Ilse A. Vermeltfoort, MD,a Pieter G. Raijmakers, PhD,a Mark Lubberink, PhD,a,c
Tjeerd Germans, PhD,b Albert C. van Rossum, PhD,b Adriaan A. Lammertsma,
PhD,a and Paul Knaapen, PhDb
Background. Positron emission tomography (PET) enables robust and reproducible
measurements of myocardial blood flow (MBF). However, the relatively limited resolution of
PET till recently prohibited distinction between the subendocardial and the subepicardial
layers in non-hypertrophied myocardium. Recent developments in hard- and software, how-
ever, have enabled to identify a transmural gradient difference in animal experiments. The aim
of this study is to determine the feasibility of subendocardial and subepicardial MBF in normal
human hearts assessed with 15O-labeled water PET.
Methods. Twenty-seven healthy subjects (mean age 41 ± 13 years; 11 men) were studied
with 15O-labeled water PET to quantify resting and hyperaemic (adenosine) MBF at a sub-
endocardial and subepicardial level. In addition, cardiac magnetic resonance imaging was
performed to determine left ventricular (LV) volumes and function.
Results. Mean rest MBF was 1.46 ± 0.49 in the subendocardium, and 1.14 ± 0.342 mL 
min21  g21 in the subepicardium (P < .001). MBF during vasodilation was augmented to a
greater extent at the subepicardial level (subendocardium vs subepicardium: 3.88 ± 0.86 vs
4.14 ± 0.88 mL  min21  g21, P 5 .013). The endocardial-to-epicardial MBF ratio decreased
significantly during hyperaemia (1.35 ± 0.23 to 1.12 ± 0.20, P < .001). Hyperaemic transmural
MBF was inversely correlated with left ventricular end-diastolic volume index (LVEDVI)
(r2 5 0.41, P 5 .0003), with greater impact however at the subendocardial level.
Conclusions. 15O-labeled water PET enables MBF measurements with distinction of the
subendocardial and subepicardial layers in the normal human heart and correlates with
LVEDVI. This PET technique may prove useful in evaluating patients with signs of ischaemia
due to coronary artery disease or microvascular dysfunction. (J Nucl Cardiol 2011;18:650–6.)
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INTRODUCTION
The subendocardium is most susceptible to perfu-
sion impairment and ischaemia principally occurs in the
subendocardium before advancing to the subepicardial
layer.1 Subendocardial perfusion imaging may therefore
be an important technique to enhance the sensitivity for
detection of myocardial ischaemia. Presently, quantifi-
cation of regional myocardial blood flow (MBF) is
available with tracers such as 15O-labeled water (H2
15O)
and positron emission tomography (PET). H2
15O PET
may therefore serve as a tool for quantifying impair-
ments in microcirculatory vasodilator reactivity.2,3
Recent advances in cardiac PET hard- and software
enable to distinguish between perfusion of the
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subendocardial and subepicardial layers in animal
experiments and patients with left ventricular hypertro-
phy.4,5 However, data in normal human hearts are
scarce. We studied the feasibility of subendocardial and
subepicardial MBF measurements in a group of healthy
volunteers using H2
15O PET during both rest and vaso-
dilator stress.
METHODS
Patient Population
Twenty-seven healthy subjects were studied. None of the
patients had a history of cardiovascular disease, all were non-
smokers, and none had any other cardiovascular risk factor.
Accordingly, none of the volunteers was receiving any form of
treatment. All underwent a physical examination, electrocar-
diography, laboratory analysis, and echocardiography
revealing no abnormalities. The characteristics of the study
group are given in Table 1. All subjects gave written informed
consent, and the protocol was approved by the Medical Ethics
Committee of the VU University Medical Centre.
Imaging Protocol
PET. All scans were performed in 2D mode using an
ECAT EXACT HR ? (Siemens/CTI, Knoxville, TN, USA).
The subjects were monitored constantly with single-lead
electrocardiography, and blood pressure was measured every
minute. After a transmission scan, 1100 MBq of H2
15O was
injected intravenously under resting conditions and subse-
quently during pharmacologically induced hyperaemia
(adenosine, 140 lg  kg-1  min-1), as described previously
in detail.4,6 Emission data were corrected for physical decay
of 15O and for dead time, scatter, randoms, and photon
attenuation. The H2
15O emission sinograms were recon-
structed using filtered back-projection with a Hanning filter
at 0.5 of the Nyquist frequency, resulting in a trans-
axial spatial resolution of *6.5 mm full-width at half-
maximum.
Cardiac magnetic resonance (CMR) imag-
ing. Scans were performed on a 1.5-T whole body scanner
(Magnetom Sonata, Siemens, Erlangen, Germany) using a six-
element phased-array radio-frequency receiver body coil. All
images were electrocardiographically gated and acquired dur-
ing repeated breath holds in mild expiration of 10-15 s,
depending on heart rate. After localization of scout scans, cine
images were acquired with a segmented balanced steady-state
free-precession sequence. The image parameters were as fol-
lows: 5 mm slice thickness, 5 mm slice gap,\50 ms temporal
resolution, 3.2 ms repetition time, 1.54 ms echo time, 60 flip
angle, and 1.3 9 1.6 mm typical image resolution. After three
long-axis view cines (2-, 3-, and 4-chamber views), a stack of
10-12 LV short-axis cines were acquired for full coverage of
the LV).7
Data Analysis
PET. Transaxial parametric MBF images were generated
as described previously.8 These images were reoriented
according to the anatomic axis of the heart, and displayed as
short-axis slices. The same reslicing parameters were applied to
the dynamic H2
15O images. Region of interests (ROIs) on these
images were defined as septal, anterior, lateral, and inferior
walls of the LV in the basal, mid, and apical planes, based on
the 16-segment model of the AHA/ACC.9 Additional ROIs
were defined for the LA and right ventricular chamber. This
latter set of ROIs was projected onto the dynamic H2
15O images
to generate image-derived input functions. The standard single-
tissue compartment model, together with these input functions,
was used to determine MBF (mL  min-1  g-1 of perfusable
tissue) for all myocardial tissue time-activity curves. The sub-
endocardial and subepicardial layers were identified by
dividing the myocardial ROIs by a central line (Figure 1).
Coronary flow reserve (CFR) was calculated as the ratio of
hyperaemic to resting MBF. A subendocardial to subepicardial
MBF ratio was additionally calculated. Because resting MBF is
determined by cardiac workload, global baseline MBF cor-
rected for the rate pressure product (RPP) was also calculated
(MBF/RPP) 9 104.10 Coronary vascular resistance (CVR) was
calculated as the ratio of mean arterial pressure to MBF for both
the subendocardial and the subepicardial layers of the
myocardium.3
CMR imaging. Epicardial and endocardial contours
were manually drawn on all end-diastolic (ED) and end-sys-
tolic (ES) LV short-axis images for LV volume analysis.
Global LV function parameters, including ED Volume
(LVEDV), ED volume adjusted for bsa (LVEDVI), ES volume
(LVESV), ejection fraction (LVEF), and myocardial mass,
were derived from epicardial and endocardial contours on the
cine images using of the MASS software package (Mass 5.0,
Medis, Leiden, The Netherlands).
Table 1. Characteristics of normal subjects
(n = 27)
Characteristics Mean ± SD
Age (years) 41 ± 13
Sex (M/F) 11/16
LVEF (%) 61 ± 5
LVESV (mL) 71 ± 17
LVEDV (mL) 180 ± 34
Mean LV mass (g) 96 ± 24
Length (cm) 177 ± 9
Weight (kg) 74 ± 13
BSA (m2) 1.9 ± 0.2
LVEDV, Left ventricular end-diastolic volume; LVEF, left ven-
tricular ejection fraction; LVESV, left ventricular end-systolic
volume; BSA, body surface area.
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Statistics
Values are expressed as means ± SD. For comparison of
two data sets, a paired or unpaired Student’s t test was per-
formed where appropriate. Multiple data sets were compared
using multivariate ANOVA, and specific differences were
identified by a Student’s t test corrected for multiple compar-
isons with the Bonferroni inequality adjustment. Linear
regression was used to analyze the relationships between
variables. All analyses were performed using SPSS 14 (SPSS,
Chicago, IL, USA). Significant differences were defined as
P \ .05.
RESULTS
Haemodynamic Parameters
Baseline heart rate was 65 ± 11, increasing to
98 ± 14 BPM during adenosine infusion (P \ .001).
Baseline systolic blood pressure was 122 ± 15, and
diastolic blood pressure 71 ± 10 mm Hg. During max-
imum vasodilatation, systolic blood pressure decreased
to 117 ± 15 and diastolic blood pressure to 64 ± 7 mm
Hg (both P \ .05 vs baseline).
Transmural MBF
Global resting transmural myocardial blood flow was
1.20 ± 0.31 and increased during hyperaemia to 3.94 ±
0.78 mL  min-1  g-1 (P = .001), yielding a CFR of
3.28 ± 0.83. Global baseline MBF corrected for rate
pressure product was 1.53 ± 0.34 mL  min-1  g-1.
Regional transmural heterogeneity. Base-
line transmural MBF for anterior, lateral, inferior, septum,
and segments was 1.30 ± 0.39, 1.29 ± 0.37, 1.08 ± 0.32,
and 1.11 ± 0.33 mL  min-1  g-1, respectively (P = .042
by ANOVA). Hyperaemic MBF increased to 3.54 ± 0.93,
4.18 ± 0.90, 3.66 ± 1.04, and 4.10 ± 0.96 mL  min-1 
g-1 for the different regions, respectively (P = .035 by
ANOVA). Transmural CFR for anterior, lateral, inferior, and
septum segments was 2.91 ± 0.91, 3.85 ± 1.15, 3.39 ±
0.74, and 3.67 ± 1.39 (P = .011 by ANOVA, using post
hoc bonferroni significant difference between septum vs
anterior P = .010).
Subendocardial vs Subepicardial MBF
As shown in Figure 2 and listed in Table 2, the
subendocardium displayed a significantly higher mean
resting flow level of 1.46 ± 0.49 compared to the mean
subepicardium level of 1.14 ± 0.42 mL  min-1  g-1
(P \ .001), with an endocardial-to-epicardial ratio of
1.35 ± 0.23. During hyperaemia, there was a significant
reduction in the endocardial-to epicardial ratio to 1.12 ±
0.20 (P \ .001), see Figure 3. Hyperemic MBF was
3.88 ± 0.86 in the subendocardium and 4.14 ±
0.88 mL  min-1  g-1 in the subepicardium (P = .013).
Hyperemic MBF increased to a greater extent at the
subepicardial level compared with the subendocardial
level, see Table 2. Baseline coronary vascular resistance
(CVR) was 67 ± 25 mm Hg  mL  min-1 and 87 ±
31 mm Hg  mL  min-1 for the subendocardial and
subepicardial layer, respectively. During hyperaemia
CVR decreases to 22 ± 7 and 21 ± 5 mm Hg 
mL  min-1, respectively.
Regional subendocardial vs subepicardial
MBF. Regional analysis for rest MBF revealed signifi-
cant differences between the subendocardial and the
subepicardial layer for all segments (all P \ .05). Dur-
ing hyperaemia PET was able to distinguish perfusion
differences between endocardium and epicardium only
in the anterior segment (P = .020) in the regional
analysis.
There were no differences for subendocardial MBF
between the four myocardial segments for resting
(P = .054) or hyperaemic (P = .511) conditions, or
CFR (P = .118). Subepicardial MBF was distributed
homogenously during rest (P = .082). During hypera-
emia, however, significant differences were observed
(P = .004) where MBF was lower in the anterior seg-
ment as compared with the septum (P = .031) and lateral
wall (P = .009). As a consequence, CFR in the anterior
wall was also lower as compared with the septum
(P = .004) and inferior wall (P = .047). No regional
differences in the endo-to-epicardial ratio between seg-
ments were observed during rest (P = .097), whereas
Figure 1. Example of delineation of subendocardial and
subepicardial border on a parametric MBF image in short axis
view at the midventricular level.
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during hyperaemia the ratio was higher in the anterior
wall compared with the septum (P = .030).
Interrelations among PET and CMR
parameters. Of the obtained PET and CMR parameters,
only LVEDVI was (inversely) correlated to hyperaemic
MBF (Figure 4). Of interest, the correlation was stronger at
the subendocardial level as compared with the subepicardial
level (P\ .05).
DISCUSSION
The ability to distinguish subendocardial from
subepicardial MBF using H2
15O PET has been investi-
gated and validated in previous studies.4,11,12,13 These
measurements, however, have been restricted to patients
with left ventricular hypertrophy to overcome the issue
of partial volume effects that are caused by the relatively
limited resolution of PET. Only recently, Rimoldi et al5
have demonstrated the feasibility to detect a transmural
perfusion gradient using H2
15O PET in an animal
experiment with pigs characterized by comparable car-
diac dimensions as normal human hearts (*10 mm wall
thickness). This study extends to these observations and
demonstrates that such a transmural perfusion gradient
can similarly be detected in normal human subjects in a
routine clinical setting with H2
15O PET.
The results show that MBF measurements in the
subendocardial layer are approximately 35% higher than
in the subepicardium during resting conditions. During
hyperaemia, augmentation of perfusion is greater at the
subepicardial level and the transmural perfusion gradient
diminishes significantly, although average subendocar-
dial MBF remains approximately 10% higher. The
combination of these observations led to an overall lower
CFR in the subendocardium. These results are in line
with data obtained from previous animal experiments
where perfusion was measured with microspheres.
Under resting conditions, subendocardial MBF is indeed
consistently higher as compared with the subepicardial
layer, with endo-to-epi flow ratios varying from *1.1 to
1.5.5,14-17 The latter observation is compatible with the
fact that, under resting conditions, myocardial perfusion
is autoregulated in response to varying metabolic
demand. As loading conditions and, consequently, oxi-
dative metabolism are greater in the subendocardial layer
of the myocardium, resting perfusion will be augmented
relative to the subepicardial layer. During hyperaemia,
however, autoregulatory mechanisms are exhausted and
myocardial perfusion is predominantly governed by
intravascular (i.e., vascular resistance) and extravascular
(i.e., diastolic perfusion time and wall stress) forces.3,18
As both intravascular and extravascular forces are
increased in the subendocardium as compared with the
subepicardial layer, a physiological transmural perfusion
gradient drop can be observed during hyperaemia rela-
tive to resting conditions, as also documented in this
study. Pathophysiological conditions that are associated
with elevated vascular resistance, irrespective of its
origin, are characterized by a greater transmural gradient
reduction and subendocardial flow frequently becomes
even lower than subepicardial flow.18 It is of interest to
note that in this study there was an inverse correlation
between LVEDV and hyperaemic MBF. Although wall
stress was not determined in these healthy subjects
owing to the invasive nature of such measurements,
according to Laplace’s law LVEDV is one of the deter-
minants of wall stress and may therefore represent a
physiological relationship between end-diastolic wall
stress and hyperaemic perfusion even within the rela-
tively small range of end-diastolic volumes in normal
subjects.19 The fact that this relation was more apparent
at the subendocardial level underscores this notion as
wall stress progressively declines from the endo- to the
epicardial level. Moreover, the relation between hype-
raemic MBF and wall stress has been documented in
previous studies, and subendocardial hyperaemic perfu-
sion can (partially) be restored by lowering end-diastolic
wall stress.4,6,12,14,20,21
Figure 2. Transmural, subendocardial, and subepicardial myocardial blood flow (MBF) during
baseline and hyperaemic conditions. Note: subendocardial baseline MBF is higher than
subepicardial (1.46 ± 0.49 vs 1.14 ± 0.42 mL  min-1  g-1, P \ .001). In contrast, hyperaemic
MBF is lower in the subendocardium (3.88 ± 0.86 vs 4.14 ± 0.88 mL  min-1  g-1, P \ .05).
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On average, transmural resting and hyperaemic
MBF values, and hence CFR, were comparable to a
previously reported large cohort of normal subjects
studied with H2
15O PET.22 Furthermore, some hetero-
geneity in both resting and hyperaemic MBF could be
detected. Although these regional variations in perfusion
may reflect a biological phenomenon, some technical
considerations must be taken into account. The model to
quantify MBF contains an intrinsic correction for spill-
over from blood activity from both the left and the right
ventricular cavity, but not from adjacent tissue. This
means that tissue surrounding the myocardium (such as
the chest wall for the anterior segments, lung tissue for
the lateral wall, and abdominal organs for the inferior
wall) could influence perfusion values and lead to slight
heterogeneity. Region definition in smaller areas of
interest, such as with subendocardial and subepicardial
flow measurements, will introduce more noise and
potentially augment spillover artifacts from adjacent
tissue. Moreover, spillover of activity between myo-
cardial layers does also occur. Simulation models and in
vivo studies have revealed that the latter will result in
underestimation of the transmural gradient.5,11
It is therefore expected that the observed perfusion
differences between layers in this study will actually be
even more pronounced. Another issue concerns the
model-based corrections for partial volume.23 This cor-
rection is warranted owing to the relatively limited
resolution of PET relative to the normal myocardial wall
thickness. This correction is fairly robust and repro-
ducible for transmural flow measurement, but might
pose limitations for smaller regions comprising only half
of the myocardial wall.24 Obviously, more studies are
warranted pertaining reproducibility. Finally, but ofT
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Figure 3. Endocardial-to-epicardial myocardial blood flow
ratio during baseline and hyperaemic conditions. During
hyperaemia, there was a significant reduction in the endocar-
dial-to epicardial ratio compared to rest (rest ratio 1.35 ± 0.23
vs stress ratio 1.12 ± 0.20 P \ .001).
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paramount importance, there is the potential of cardiac
and respiratory gating to further enhance the accuracy of
subendocardial and subepicardial flow measurements.
This study was conducted without cardiac or respiratory
gating as count statistics per gated frame would become
insufficient for dynamic quantitative H2
15O perfusion
imaging. Nonetheless, recent studies have clearly dem-
onstrated that such gating sequences substantially
improve spatial resolution.25,26 With the aid of list mode
acquisition as well as time-of-flight sequences, future
studies will certainly need to focus on the applicability
of cardiac and respiratory gating to increase the spatial
resolution in dynamic quantitative PET imaging to
facilitate measurements of transmural myocardial per-
fusion gradients.27,28
CLINICAL IMPLICATIONS
It seems that PET measurements of subendocardial/
subepicardial flow ratio can be used as an index for
subendocardial perfusion, using the subepicardial per-
fusion as a reference. Normal values of subendocardial
perfusion and the subendocardial/subepicardial flow
ratio are of potential clinical importance for identifying
patients at risk of subendocardial ischaemia. In a recent
study, a decreased subendocardial/subepicardial flow
ratio was found by PET for patients with hypertrophied
hearts indicating microvascular dysfunction.4 Coronary
microvascular dysfunction is probably also the cause of
the angina in a subgroup of cardiac syndrome X patients
(angina-like chest pain in the absence of obstructive
CAD).29,30 Rosen et al31 reported however that no sig-
nificant transmural MBF differences existed between
cardiac syndrome X patients and controls using
15O-labeled water PET. However, this does not exclude
subendocardial ischaemia in this group of patients.32,33
Further studies using PET may reveal possible suben-
docardial ischemia in patients with cardiac syndrome X.
Hence quantification of regional myocardial blood flow
may be clinically useful not only for assessing the extent
and severity of coronary vascular disease, but also to
detect and measure impairments in microcirculatory
function in non-coronary cardiac disease. The prognos-
tic significance of transmural microcirculatory dysfunc-
tion in the absence of CAD, however, remains to be
assessed.
CONCLUSIONS
This study demonstrates the feasibility of using
15O-labeled water positron emission tomography (PET)
to measure myocardial blood flow in both the suben-
docardial and the subepicardial layers of a left ventricle
of normal thickness. This PET technique may prove
useful in evaluating patients with signs of ischaemia due
to microvascular dysfunction.
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